乳腺癌根治术后放疗中组织等效填充物使用的研究进展

doi:10.3760/cma.j.cn113030-20210926-00371

摘要
图/表
参考文献(38)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要乳房切除术后放疗（PMRT）的使用已被证明为乳腺癌患者带来生存获益,但关于组织等效填充物（bolus）的使用仍存在争议。近年来大量研究表明PMRT中bolus的使用并不会显著提高患者的局部控制率,却因此明显增加了患者的急性皮肤不良反应,甚至可能导致更频繁和更长时间的治疗中断。现有的回顾性研究均表明对于接受乳房切除术和全身治疗的乳腺癌患者,如无皮肤侵犯,则建议在放疗期间不常规使用bolus,但还需要更高级别的临床研究进一步证实。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	陈黎
	钱建军
	田野

关键词 ：乳腺肿瘤, 乳房切除术后放射疗法, 组织补偿物, 皮肤不良反应, 急性/晚期, 局部控制率

Abstract：Although the use of postmastectomy radiation therapy (PMRT) has been proven to bring survival benefit to breast cancer patients, the use of chest wall tissue equivalent filler (bolus) remains controversial. In recent years, a large number of studies have shown that the use of bolus in PMRT does not significantly improve the local control rate, while it can significantly increase the acute skin toxicity, and even leads to more frequent and longer treatment interruption. Existing retrospective studies have indicated that for breast cancer patients undergoing mastectomy and systemic therapy, if there is no skin invasion, it is recommended not to routinely use bolus during radiotherapy. However, higher-level clinical studies are needed for further confirmation.

Key words： Breast neoplasms Post-mastectomy radiotherapy Tissue-equivalent material Skin toxicity acute / late Local control rate

收稿日期: 2021-09-26

基金资助:江苏省医学创新团队A类（CXDT-37）

通讯作者: 钱建军,Email：qianjianjun0628@aliyun.com

引用本文:

陈黎,钱建军,田野. 乳腺癌根治术后放疗中组织等效填充物使用的研究进展[J]. 中华放射肿瘤学杂志, 2023, 32(2): 184-188.

Chen Li,Qian Jianjun,Tian Ye. Research progress on use of tissue equivalent filler in postmastectomy radiation therapy of breast cancer[J]. Chinese Journal of Radiation Oncology, 2023, 32(2): 184-188.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20210926-00371 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2023/V32/I2/184

[1] Martijn H, Caspers RJ, Welvaart K, et al.Locally advanced breast cancer: radiotherapy alone versus surgery and radiotherapy[J]. Radiother Oncol, 1989,16(1):23-29. DOI: 10.1016/0167-8140(89)90067-4.
[2] Weichselbaum RR, Marck A, Hellman S.The role of postoperative irradiation in carcinoma of the breast[J]. Cancer, 1976,37(6):2682-2690. DOI: 10.1002/1097-0142(197606)37:6<2682::aid-cncr2820370617>3.0.co;2-w.
[3] Nakamura N, Arahira S, Zenda S, et al.Post-mastectomy radiation therapy without usage of a bolus may be a reasonable option[J]. J Radiat Res, 2017,58(1):66-70. DOI: 10.1093/jrr/rrw055.
[4] Shiba S, Okamoto M, Kiyohara H, et al.Clinical advantage of chest-wall post-mastectomy radiation therapy without bolus[J]. In Vivo, 2018,32(4):961-965. DOI: 10.21873/invivo.11335.
[5] Recht A, Edge SB, Solin LJ, et al.Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology[J]. J Clin Oncol, 2001,19(5):1539-1569. DOI: 10.1200/JCO.2001.19.5.1539.
[6] Vu TT, Pignol JP, Rakovitch E, et al.Variability in radiation oncologists' opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey[J]. Clin Oncol (R Coll Radiol), 2007,19(2):115-119. DOI: 10.1016/j.clon.2006.10.004.
[7] Gradishar WJ, Anderson BO, Abraham J, et al.Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020,18(4):452-478. DOI: 10.6004/jnccn.2020.0016.
[8] Kaidar-Person O, Vrou Offersen B, Hol S, et al.ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer[J]. Radiother Oncol, 2019,137:159-166. DOI: 10.1016/j.radonc.2019.04.010.
[9] 中国医师协会放射肿瘤治疗医师分会. 乳腺癌放射治疗指南(中国医师协会2020版)[J].中华放射肿瘤学杂志,2021,30(4):321-342. DOI: 10.3760/cma.j.cn113030-202101 07-00010.
Branch of Radiotherapy Oncologists of Chinese Physician Association. Guidelines for radiotherapy of breast cancer (Chinese Medical Doctor Association 2020 edition)[J].Chin J Radiat Oncol, 2021,30(4):321-342. DOI: 10.3760/cma.j.cn113030-20210107-00010.
[10] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J].中国癌症杂志,2019,29(8):609-679. DOI: 10.19401/j.cnki.1007-3639.2019.08.009.
Breast Cancer Professional Committee of Chinese Anti-Cancer Society. Guidelines and norms for diagnosis and treatment of breast cancer by Chinese Anti-cancer Association (version 2019)[J]. Chin Oncol, 2019,29(8):609-679. DOI: 10.19401/j.cnki.1007-3639.2019.08.009.
[11] Manger R, Paxton A, Cerviño L.Dosimetric assessment of brass mesh bolus for postmastectomy photon radiotherapy[J]. J Appl Clin Med Phys, 2016,17(6):86-96. DOI: 10.1120/jacmp.v17i6.6221.
[12] Al-Rahbi ZS, Cutajar DL, Metcalfe P, et al.Dosimetric effects of brass mesh bolus on skin dose and dose at depth for postmastectomy chest wall irradiation[J]. Phys Med, 2018,54:84-93. DOI: 10.1016/j.ejmp.2018.09.009.
[13] Grellier Adedjouma N, Chevrier M, Fourquet A, et al.Long-term results of a highly performing conformal electron therapy technique for chest wall irradiation after mastectomy[J]. Int J Radiat Oncol Biol Phys, 2017,98(1):206-214. DOI: 10.1016/j.ijrobp.2017.01.205.
[14] Fujimoto K, Shiinoki T, Yuasa Y, et al.Efficacy of patient-specific bolus created using three-dimensional printing technique in photon radiotherapy[J]. Phys Med, 2017,38:1-9. DOI: 10.1016/j.ejmp.2017.04.023.
[15] Kawamoto T, Shikama N, Kurokawa C, et al.Dosimetric assessment of bolus for postmastectomy radiotherapy[J]. Med Dosim, 2021,46(1):e1-e4. DOI: 10.1016/j.meddos.2020.08.001.
[16] Dahn HM, Boersma LJ, de Ruysscher D, et al. The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review[J]. Crit Rev Oncol Hematol, 2021,163:103391. DOI: 10.1016/j.critrevonc.2021. 103391.
[17] Kawamoto T, Shikama N, Kurokawa C, et al.A prospective feasibility study of a 1-mm bolus for postmastectomy radiotherapy[J]. BMC Cancer, 2021,21(1):109. DOI: 10.1186/s12885-021-07851-3.
[18] Rossi M, Boman E, Kapanen M.Optimal selection of optimization bolus thickness in planning of VMAT breast radiotherapy treatments[J]. Med Dosim, 2019,44(3):266-273. DOI: 10.1016/j.meddos.2018.10.001.
[19] Wong G, Lam E, Bosnic S, et al.Quantitative effect of bolus on skin dose in postmastectomy radiation therapy[J]. J Med Imaging Radiat Sci, 2020,51(3):462-469. DOI: 10.1016/j.jmir.2020.06.006.
[20] Aras S, Tanzer İO, İkizceli T.Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice[J]. Eur J Breast Health, 2020,16(3):167-170. DOI: 10.5152/ejbh.2020.5041.
[21] Manger R, Paxton A, Cerviño L.Dosimetric assessment of brass mesh bolus for postmastectomy photon radiotherapy[J]. J Appl Clin Med Phys, 2016,17(6):86-96. DOI: 10.1120/jacmp.v17i6.6221.
[22] Khan Y, Villarreal-Barajas JE, Udowicz M, et al. Clinical and dosimetric implications of air gaps between bolus and skin surface during radiation therapy[J]. J Cancer Ther, 2013,4(7):1251-1255. DOI: 10.4236/jct.2013. 47147.
[23] Wu CHD, Long K, Logie N, et al. Dosimetric evaluation of chest wall superficial dose with or without bolus in postmastectomy radiotherapy[J]. Int J Rad Onc Biol Phys, 2020,108(3):e341-e342. DOI: 10.1016/j.ijrobp.2020. 07.815.
[24] Smith NL, Jethwa KR, Viehman JK, et al.Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications[J]. Radiother Oncol, 2019,140:76-83. DOI: 10.1016/j.radonc.2019. 05.022.
[25] Luo L, Cuaron J, Braunstein L, et al.Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy[J]. Radiother Oncol, 2019,132:250-256. DOI: 10.1016/j.radonc.2018.10.002.
[26] Pignol JP, Vu TT, Mitera G, et al.Prospective evaluation of severe skin toxicity and pain during postmastectomy radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2015,91(1):157-164. DOI: 10.1016/j.ijrobp.2014.09.022.
[27] Tieu MT, Graham P, Browne L, et al.The effect of adjuvant postmastectomy radiotherapy bolus technique on local recurrence[J]. Int J Radiat Oncol Biol Phys, 2011,81(3):e165-171. DOI: 10.1016/j.ijrobp.2011.01.002.
[28] Turner JY, Zeniou A, Williams A, et al.Technique and outcome of post-mastectomy adjuvant chest wall radiotherapy-the role of tissue-equivalent bolus in reducing risk of local recurrence[J]. Br J Radiol, 2016,89(1064):20160060. DOI: 10.1259/bjr.20160060.
[29] Yap ML, Tieu M, Sappiatzer J, et al.Outcomes in patients treated with post-mastectomy chest wall radiotherapy without the routine use of bolus[J]. Clin Oncol (R Coll Radiol), 2018,30(7):427-432. DOI: 10.1016/j.clon.2018. 03.005.
[30] Boulle G, Saint-Martin C, De La Lande B, et al. Photons without bolus versus electrons with bolus after upfront mastectomy without immediate reconstruction in breast cancer patients[J]. Int J Radiat Oncol Biol Phys, 2019,104(4):877-884. DOI: 10.1016/j.ijrobp.2019.03.029.
[31] Brown L, Harmsen W, Blanchard M, et al.Once-daily radiation therapy for inflammatory breast cancer[J]. Int J Radiat Oncol Biol Phys, 2014,89(5):997-1003. DOI: 10.1016/j.ijrobp.2014.01.054.
[32] Damast S, Ho AY, Montgomery L, et al.Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era[J]. Int J Radiat Oncol Biol Phys, 2010,77(4):1105-1112. DOI: 10.1016/j.ijrobp.2009.06.042.
[33] Uematsu M, Bornstein BA, Recht A, et al.Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer[J]. Int J Radiat Oncol Biol Phys, 1993,25(5):765-770. DOI: 10.1016/0360-3016(93)90303-d.
[34] Kumar V, Abbas A, Fausto N. (2010). Robbins and Cotran Pathologic Basis of Disease[M]. 8th ed. Philadelphia, PA: Elsevier, 2010.
[35] Abel S, Renz P, Trombetta M, et al.Local failure and acute radiodermatological toxicity in patients undergoing radiation therapy with and without postmastectomy chest wall bolus: is bolus ever necessary?[J]. Pract Radiat Oncol, 2017,7(3):167-172. DOI: 10.1016/j.prro.2016. 10.018.
[36] Murray Brunt A, Haviland JS, Wheatley DA, et al.Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial[J]. Lancet, 2020,395(10237):1613-1626. DOI: 10.1016/S0140-6736(20)30932-6.
[37] Brunt AM, Haviland JS, Sydenham M, et al.Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer[J]. J Clin Oncol, 2020,38(28):3261-3272. DOI: 10.1200/JCO.19.02750.
[38] Yarnold J, Bentzen SM, Coles C, et al.Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities[J]. Int J Radiat Oncol Biol Phys, 2011,79(1):1-9. DOI: 10.1016/j.ijrobp.2010.08.035.